US FDA approves Vertex Pharma's triple combo cystic fibrosis treatment-March 2024-www.financetom.com

US FDA approves Vertex Pharma's triple combo cystic fibrosis treatment

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

US FDA approves Vertex Pharma's triple combo cystic fibrosis treatment

Dec 20, 2024 1:22 PM

Dec 20 (Reuters) - The U.S. Food and Drug Administration

has approved Vertex Pharmaceuticals' ( VRTX ) next-generation

treatment for a rare and progressive genetic disease, the

company said on Friday, expanding its dominance in the market

for cystic fibrosis.

Previous page： F&G Annuities & Life Insider Bought Shares Worth $469,650, According to a Recent SEC Filing Next page： Google agrees $36 million fine for anti-competitive deals with Australia telcos

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

F&G Annuities & Life Insider Bought Shares Worth $469,650, According to a Recent SEC Filing

May 26, 2025

04:42 PM EDT, 05/12/2025 (MT Newswires) -- Christopher O Blunt, Director, Chief Executive Officer, on May 12, 2025, executed a purchase for 15,000 shares in F&G Annuities & Life ( FG ) for $469,650. Following the Form 4 filing with the SEC, Blunt has control over a total of 874,964 common shares of the company, with 874,964 shares held directly....

Google agrees $36 million fine for anti-competitive deals with Australia telcos

Aug 17, 2025

SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...

Guardian Pharmacy Services Q1 Revenue Rises; Eyes Upper end of 2025 Revenue Outlook

May 26, 2025

04:42 PM EDT, 05/12/2025 (MT Newswires) -- Guardian Pharmacy Services ( GRDN ) reported Q1 net income late on Monday of $0.15 per diluted share. Per-Share earnings for the year-earlier period were not available. Two analysts polled by FactSet expected $0.22. Revenue for the quarter ended March 31 was $329.3 million, up from $275.4 million a year earlier. Two analysts...

BRIEF-EGH Acquisition Completes $150,000,000 Initial Public Offering

May 26, 2025

May 12 (Reuters) - EGH Acquisition Corp ( EGHAU ): * EGH ACQUISITION CORP. ( EGHAU ) COMPLETES $150,000,000 INITIAL PUBLIC OFFERING Source text: Further company coverage: ...